• Pfizer average return on equity for 2023 was 16.42, a 52.67% decline from 2022.
• Pfizer average return on equity for 2022 was 34.69, a 48.76% decline from 2021.
• Pfizer average return on equity for 2021 was 23.32, a 29.48% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.